Female Cialis (Tadalafil 20mg, Off-Label)
Female Cialis is a marketing name for tadalafil 20mg tablets sold to women through international online pharmacies. The product is not approved for any female sexual indication and is positioned off-label, despite the popular name.
- Active ingredients
- Tadalafil
- Manufacturer
- Various generics
- Dosage forms
- tablet
- Available dosages
- 20mg
- Category
- Women's Sexual Health
What is it?
Female Cialis is a marketing label used by international online pharmacies for tadalafil 20mg tablets sold to women. Despite the name, the product is not approved by the FDA, EMA or other major regulators for the treatment of female sexual dysfunction. The active ingredient, tadalafil, is the same molecule used in standard Cialis; manufacturers vary, and the regulatory status of any specific batch depends on local registration. The marketing positions it as a long-acting alternative to Female Viagra, leveraging tadalafil's 36-hour effect window.
Active ingredients
Each tablet contains 20mg of tadalafil, the same selective PDE5 inhibitor used for erectile dysfunction in men. The pharmacological mechanism — increasing genital blood flow through cGMP accumulation — is theoretically applicable to women, since PDE5 is also present in female genital tissue. However, controlled trials of tadalafil for female sexual arousal disorder are limited and inconsistent, and the molecule has not received approval for any female sexual indication.
Forms and dosages
Female Cialis is supplied as 20mg film-coated tablets, sometimes pink in colour to differentiate from standard Cialis. International online pharmacies typically recommend one tablet 30 to 60 minutes before planned sexual activity. Because there is no approved indication, no formal dosing schedule applies. Lower doses of tadalafil have been used in some clinical research. According to general prescribing principles, dose decisions should be made by a qualified clinician.
Indications
Female Cialis has no approved indication. Major regulators have not authorised tadalafil for any female sexual dysfunction. The FDA-approved options for hypoactive sexual desire disorder in premenopausal women are flibanserin (Addyi) and bremelanotide (Vyleesi), which work through different mechanisms. According to clinical guidelines, off-label use of tadalafil by women should not be undertaken without medical supervision.
How it works
Tadalafil inhibits PDE5, allowing cGMP to accumulate in vascular smooth muscle and increasing local blood flow during arousal. In men this supports erection; in women, the theory is that increased genital blood flow could improve arousal and lubrication. Clinical trial evidence in women is limited, and no major regulator has accepted it for approval. Sexual stimulation is required for any expected effect, and the molecule does not act on desire — the dominant complaint in many female sexual dysfunctions.
Frequently asked questions
Is Female Cialis FDA-approved? ▾
No. Despite the marketing name, tadalafil has no FDA approval for any female sexual indication. The two FDA-approved treatments for hypoactive sexual desire disorder in premenopausal women are flibanserin (Addyi) and bremelanotide (Vyleesi). Tadalafil-based products sold as Female Cialis are off-label and unauthorised for female use, regardless of how they are marketed.
How does Female Cialis differ from Female Viagra? ▾
Female Cialis contains tadalafil 20mg, while Female Viagra contains sildenafil 100mg. Both are off-label PDE5 inhibitors marketed for women, both work through similar mechanisms (increased genital blood flow), and neither is approved by major regulators for female use. The main pharmacological difference is duration: tadalafil has a 36-hour effect window versus sildenafil's 4 hours. Female Cialis is positioned for women who prefer the longer window.
Does Female Cialis work for low libido? ▾
Tadalafil, the active ingredient, does not act on sexual desire and is unlikely to help with hypoactive sexual desire disorder. It targets blood flow rather than central nervous system desire pathways. For low libido in premenopausal women, the FDA-approved options are flibanserin and bremelanotide. According to clinical guidelines, low desire should be evaluated medically before any pharmacological treatment.
Are there safety concerns specific to women using Female Cialis? ▾
Standard tadalafil contraindications apply: nitrate co-administration is contraindicated due to severe hypotension risk, and severe cardiovascular disease, recent stroke or heart attack, severe hepatic impairment and known tadalafil hypersensitivity require caution. Safety data in pregnancy and breastfeeding is limited. According to regulators, the additional risk of counterfeit material in unverified online channels should be considered.
What evidence-based options exist for female sexual concerns? ▾
Evidence-based options include FDA-approved medications for hypoactive sexual desire disorder (flibanserin, bremelanotide), hormone therapy in postmenopausal women, cognitive-behavioral therapy, couples counselling and treatment of any underlying medical or psychiatric conditions. According to clinical guidelines, evaluation by a qualified clinician — gynaecologist, urologist or sexual medicine specialist — should precede any pharmacological treatment.
Related medications
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.